250 related articles for article (PubMed ID: 17465985)
1. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
Marques RC; Dórea JG; Manzatto AG; Bastos WR; Bernardi JV; Malm O
Acta Paediatr; 2007 Jun; 96(6):864-8. PubMed ID: 17465985
[TBL] [Abstract][Full Text] [Related]
2. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
Marques RC; Dórea JG; Bernardi JV
Acta Paediatr; 2010 Jun; 99(6):934-9. PubMed ID: 20003103
[TBL] [Abstract][Full Text] [Related]
3. Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury.
Marques RC; Bernardi JV; Dórea JG; Bastos WR; Malm O
Int J Hyg Environ Health; 2008 Oct; 211(5-6):606-14. PubMed ID: 18160342
[TBL] [Abstract][Full Text] [Related]
4. Milestone achievement and neurodevelopment of rural Amazonian toddlers (12 to 24 months) with different methylmercury and ethylmercury exposure.
Dórea JG; Marques RC; Abreu L
J Toxicol Environ Health A; 2014; 77(1-3):1-13. PubMed ID: 24555642
[TBL] [Abstract][Full Text] [Related]
5. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
Dórea JG; Marques RC; Brandão KG
Am J Perinatol; 2009 Aug; 26(7):523-7. PubMed ID: 19283656
[TBL] [Abstract][Full Text] [Related]
6. Prenatal and postnatal mercury exposure, breastfeeding and neurodevelopment during the first 5 years.
Marques RC; Dórea JG; Bernardi JV; Bastos WR; Malm O
Cogn Behav Neurol; 2009 Jun; 22(2):134-41. PubMed ID: 19506431
[TBL] [Abstract][Full Text] [Related]
7. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
8. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
[TBL] [Abstract][Full Text] [Related]
10. Speciation of methyl- and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines.
Dórea JG; Bezerra VL; Fajon V; Horvat M
Clin Chim Acta; 2011 Aug; 412(17-18):1563-6. PubMed ID: 21575620
[TBL] [Abstract][Full Text] [Related]
11. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
[TBL] [Abstract][Full Text] [Related]
12. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
13. Maternal mercury exposure and neuro-motor development in breastfed infants from Porto Velho (Amazon), Brazil.
Marques RC; Garrofe Dórea J; Rodrigues Bastos W; de Freitas Rebelo M; de Freitas Fonseca M; Malm O
Int J Hyg Environ Health; 2007 Jan; 210(1):51-60. PubMed ID: 17011234
[TBL] [Abstract][Full Text] [Related]
14. Hair mercury in breast-fed infants exposed to thimerosal-preserved vaccines.
Marques RC; Dórea JG; Fonseca MF; Bastos WR; Malm O
Eur J Pediatr; 2007 Sep; 166(9):935-41. PubMed ID: 17237965
[TBL] [Abstract][Full Text] [Related]
15. Changes in children hair-Hg concentrations during the first 5 years: maternal, environmental and iatrogenic modifying factors.
Marques RC; Dórea JG; Bastos WR; Malm O
Regul Toxicol Pharmacol; 2007 Oct; 49(1):17-24. PubMed ID: 17566620
[TBL] [Abstract][Full Text] [Related]
16. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.
Stajich GV; Lopez GP; Harry SW; Sexson WR
J Pediatr; 2000 May; 136(5):679-81. PubMed ID: 10802503
[TBL] [Abstract][Full Text] [Related]
17. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
[TBL] [Abstract][Full Text] [Related]
18. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Parker SK; Schwartz B; Todd J; Pickering LK
Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
[TBL] [Abstract][Full Text] [Related]
19. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
Verstraeten T; Davis RL; DeStefano F; Lieu TA; Rhodes PH; Black SB; Shinefield H; Chen RT;
Pediatrics; 2003 Nov; 112(5):1039-48. PubMed ID: 14595043
[TBL] [Abstract][Full Text] [Related]
20. Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors.
Dórea JG
Am J Perinatol; 2007 Aug; 24(7):387-400. PubMed ID: 17564957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
